Direct-to-Consumer Advertising of Drugs: Should We Change It and, If So, How?
Nov 10, 2016 - 6:30 p.m. to 8:00 p.m.
Event will be held online
The Columbia University Bioethics program is pleased to invite you to a series of free, online webinars examining critical ethical and policy issues that arise in the context of drug and device development and the pharmaceutical industry. Our first webinar will focus on ethical questions posed by Direct-to-Consumer (DTC) pharmaceutical advertising.
The United States and New Zealand are the only countries that allow DTC pharmaceutical advertising. Supporters of DTC advertising argue that it represents free speech and informs patients about possible treatments while others argue that limits should be imposed. Dr. Robert Klitzman will moderate a discussion on these timely and important ethical questions regarding DTC advertising with an extraordinary panel of distinguished speakers.
For further information, please contact Lillian Ringel at email@example.com.
Dr. Robert Klitzman, Director, M.S. in Bioethics program, Columbia University
Richard Meyer, former Eli Lilly marketing executive and current pharmaceutical consultant
Richard Kravitz, M.D., MSPH, Professor and Co-Vice Chair of Research, Department of Internal Medicine, UC Davis
Tony Russo, Ph.D., Chairman and CEO, Russo Partners LLC
Ed Silverman, Senior Writer and Pharmalot columnist, STAT News
Diana Zuckerman, Ph.D., President, National Center for Health Research